Larvol Delta - A-Clinical-Trial-of-CK0801-a-New-Drug-In-Patients-With-TreatmentResistant-GuillainBarre-Syndrome-GBS

CK0801 - Cellenkos

http://clinicaltrials.gov/ct2/show/NCT03773328

Jul 20, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next